EUVIMEDEUVIMED entdecken
Crossref

Siglec-15 Enhances Cisplatin Resistance in Cervical Cancer Cells by Promoting Mitochondrial Retrograde Signaling Through Activation of the MAPK Pathway

Zenghui Li, Junwei Zhao, Li Hao, Jing Wang iD

DNA and Cell Biology · 01.09.2026 · 45 (9) · 458-469

DOI: 10.1177/10445498261470989 ↗

Kurz gefasst

Fachartikel in der Zeitschrift DNA and Cell Biology, online erschienen am 23.07.2026. Verfasst von Zenghui Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Yantai Yuhuangding Hospital, Yantai, China. Hauptthemen laut MEDLINE: Cisplatin, Uterine Cervical Neoplasms, Drug Resistance, Neoplasm, Mitochondria. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemoresistance constitutes a major cause of poor prognosis in advanced cervical cancer. Our previous studies have confirmed that Siglec-15 affects the progression of cervical cancer, whereas its role in regulating cervical cancer chemoresistance remains unexplored. This study investigates the role of Siglec-15 in cervical cancer chemoresistance and explores its mechanism. Siglec-15 expression and mitochondrial retrograde signaling levels were compared between parental and cisplatin-resistant cervical cancer cells. Lentiviral transfection was used to assess the functional effects of Siglec-15 modulation on the proliferation, apoptosis, and chemosensitivity of resistant cells. Further investigations were conducted to examine the effects of Siglec-15 on the mitogen-activated protein kinase (MAPK) signaling pathway, mitochondrial membrane potential, reactive oxygen species levels, and the expression of retrograde-related proteins. These in vitro findings were subsequently validated in vivo using a xenograft tumor model through immunohistochemistry, Terminal-deoxynucleotidyl transferase-mediated dUTP-nick-end labeling (TUNEL) assays, and western blotting. The results showed that Siglec-15 was markedly upregulated in cisplatin-resistant cervical cancer cells, correlating with enhanced mitochondrial retrograde signaling. Siglec-15 overexpression promoted cisplatin resistance and mitochondrial retrograde signaling, driving proliferation while inhibiting apoptosis. Mechanistically, Siglec-15 regulated mitochondrial retrograde signaling through activation of the MAPK pathway, thereby enhancing chemoresistance in drug-resistant cells. Elevated Siglec-15 expression enhances cisplatin resistance in cervical cancer cells by activating the MAPK pathway to promote mitochondrial retrograde signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinUterine Cervical NeoplasmsDrug Resistance, NeoplasmMitochondriaMAP Kinase Signaling SystemHumansFemaleAnimalsApoptosisCell ProliferationCell Line, TumorMiceMice, NudeAntineoplastic AgentsMembrane Potential, MitochondrialSignal TransductionGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

MAPK pathwaySiglec-15cervical cancercisplatin resistancemitochondrial retrograde signaling

Substanzen

CisplatinAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Gynecology, Yantai Yuhuangding Hospital, Yantai, China.

ORCID-Profile: Jing Wang

Zitieren

APA

Li, Z., Zhao, J., Hao, L., & Wang, J. (2026). Siglec-15 Enhances Cisplatin Resistance in Cervical Cancer Cells by Promoting Mitochondrial Retrograde Signaling Through Activation of the MAPK Pathway. DNA and Cell Biology, 45(9), 458-469. https://doi.org/10.1177/10445498261470989

Vancouver

Li Z, Zhao J, Hao L, Wang J. Siglec-15 Enhances Cisplatin Resistance in Cervical Cancer Cells by Promoting Mitochondrial Retrograde Signaling Through Activation of the MAPK Pathway. DNA and Cell Biology. 2026;45(9):458-469. doi:10.1177/10445498261470989

BibTeX
@article{Li2026,
  author = {Li, Zenghui and Zhao, Junwei and Hao, Li and Wang, Jing},
  title = {Siglec-15 Enhances Cisplatin Resistance in Cervical Cancer Cells by Promoting Mitochondrial Retrograde Signaling Through Activation of the MAPK Pathway},
  journal = {DNA and Cell Biology},
  year = {2026},
  volume = {45},
  number = {9},
  pages = {458--469},
  doi = {10.1177/10445498261470989}
}
Kostenlos starten →